CanBas Co., Ltd. Aktie - Unternehmensdaten & Kurse - JP3244570002 | goSPATZ

CanBas Co., Ltd.

Share · JP3244570002 (XTKS)

No Price

Closing Price XTKS 09.12.2025: 833,00 JPY

09.12.2025 05:40

Current Prices from CanBas Co., Ltd.

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
Tokyo	4575.T	JPY	09.12.2025 05:40	833,00 JPY	-15,00 JPY -1,77 %

Share Float & Liquidity

Free Float 92,63 %

Shares Float 18,25 M

Shares Outstanding 19,7 M

Company Profile for CanBas Co., Ltd. Share

CanBas Co., Ltd., a clinical stage biopharmaceutical company, develops therapeutics for cancer patients. It develops CBP501, a calmodulin-modulating peptide to treat various cancer; and CBS9106, a reversible exportin-1inhibitor that is in Phase I clinical trial for the treatment of solid tumors. The company has a collaboration alliance with Stemline Therapeutics, Inc. CanBas Co., Ltd. was incorporated in 2000 and is based in Numazu, Japan.

Get up to date insights from finAgent about CanBas Co., Ltd.

Company Data

Name CanBas Co., Ltd.

Company CanBas Co., Ltd.

Website https://www.canbas.co.jp

Primary Exchange

Tokyo

ISIN JP3244570002

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Takumi Kawabe

Market Capitalization 16 Mrd.

Country Japan

Currency JPY

Employees 0,0 T

Address 2-2-1, Otemachi, 410-0801 Numazu

IPO Date 2009-09-17

Ticker Symbols

Name	Symbol
Tokyo	4575.T

More Shares

Investors who hold CanBas Co., Ltd. also have the following shares in their portfolio:

Kurogane Kosakusho Ltd. Share

REP. FSE 17-27 O.A.T. Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025